NBD AI Bulletin -- Sichuan Kelun Pharmaceutical Co., Ltd (SZ 002422, close price: 17.87 yuan) on May 26 announced that as of the date of the announcement, the Company's 2021 employee stock ownership plan (ESOP) bought 630,000 shares in the Company.
In 2021, the operating income of Sichuan Kelun Pharmaceutical mainly came from the pharmaceutical manufacturing industry (98.02%).
Sichuan Kelun Pharmaceutical's chairman is Liu Gexin, male, 71 years old, with a master's degree. Sichuan Kelun Pharmaceutical's general manager is Liu Sichuan, male, 38 years old, with a master's degree.
(By Gao Han)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.